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1. Introduction 
Over the past few decades, there has been a dramatic increase in the prevalence of obesity in 
many countries. The World Health Organization (WHO) estimates that more than 1 billion 
adults worldwide are overweight; of these, at least 300 millions are obese. (1) Obesity is 
associated with multiple chronic diseases, including type 2 diabetes, hypertension, coronary 
heart disease, stroke and several cancers.(2) 
Definitions of overweight (BMI >25) and obesity (BMI>30) are based essentially on criteria 
derived from studies that involved populations of European origin. The validity of these 
criteria in Asian populations has yet to be determined. It has been suggested that the 
associations of BMI with body composition and health outcomes may differ between Asian 
and European populations. Studies have shown that for a given BMI, Asians generally have 
a higher percentage of body fat than do Europeans. Asian populations have also been 
shown to have elevated risks of type 2 diabetes, hypertension, and hyperlipidemia at a 
relatively low level of BMI.(3)   
2. Obesity in Asia 
In most Asian countries, the prevalence of overweight and obesity have increased many 
times over in the past few decades, and the magnitude varies between countries (4,5,6). 
Southeast Asia and the Western Pacific region are currently facing an epidemic of diseases 
associated with obesity such as diabetes and CVD. India has the highest number of people 
with diabetes in the world and China occupies the second position (7). 
Table 1 (8) shows the prevalence of overweightness and obesity in Asian countries in 
comparison with the United States. Many Asian countries have rates which are not very 
different from that of the U.S. 
The highest rate of obesity in Asia is in Thailand(9) and the lowest is in India (6) followed by 
Philippines (10). China, which once had the leanest of populations, is now rapidly catching 
up with the West in terms of prevalence of overweight and obesity which had occurred in a 
remarkably short time (11,12) 
The obesity pandemic was restricted to developed, high-income countries until a few 
decades ago, but recently it has penetrated even the poorest of nations. Asia has undergone 
considerable socioeconomic transition in the last three decades, which has resulted in 
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increased availability of food, better transport facilities and better health care facilities. The 
changing trend was seen first in urban populations and in recent years, with improving 
socioeconomic scenarios in rural areas, the changes were seen even among the urbanizing 
rural populations. The recent epidemiological data among urban and semi urban southern 
Indian populations illustrates the changing scenario (13). In addition, reduced physical 
activity at work due to mechanization, improved motorized transport and preferences for 
viewing television and video games to outdoor games during leisure time, have resulted in 
positive energy balance in most Asian countries (14). 
 
 
Survey year Prevalence of overweight 
adults (%) 
Prevalence of obese adult 
(%) 
United States 2007-2008 34.0 0.2 
India 1998-1999 10.0 2.2 
Malaysia 1996-1997 16.6 4.4 
Philippines 1998 16.9 3.3 
Taiwan 1993–1996 21.1 4.0 
Japan 2001 23.0 3.0 
Singapore 1998 24.4 6.0 
China 1999-2000 25.0 4.0 
Hong Kong 1996-1997 25.1 3.8 
South Korea 2001 27.4 3.2 
Table 1. Comparison of prevalence of adult obesity in Asian countries versus the United 
States. 
In parallel with the increase in adult obesity, obesity in children is also increasing. 
Childhood obesity has reached more than 25% in many developing countries. The 
etiological factors for childhood obesity include genetic, metabolic, and behavioral 
components. An imbalanced energy intake versus energy expenditure due to consumption 
of energy dense food and increase in sedentary habits has mainly contributed to increases in 
childhood obesity, both in developed and developing countries (15). 
Asian populations generally have a lower BMI than many other ethnic groups, but the 
association between BMI and glucose intolerance is as strong as in any other population 
(16). The risk of diabetes (odds ratio) was significant for urban Indian populations with a 
BMI of >23kg/m2 (17). This has been confirmed by studies from other parts of India (18), by 
studies in migrant Indians and in other Asian populations (19). According to WHO 
recommendations, a BMI of 18.5–22kg/m2 is considered healthy for Asian populations (20). 
Insulin resistance is one of the major etiological factors for diabetes and the risk association 
between obesity and diabetes is mediated through insulin resistance. 
Many Asian populations have a higher total and central adiposity for a given body weight 
when compared to matched Caucasian populations. A higher prevalence of metabolic 
syndrome in south Asians is mostly attributed to the higher prevalence of central adiposity. 
The IDF criteria for metabolic syndrome recommends use of ethnic specific thresholds for 
waist circumference, which includes ≥ 90 cm in men, and ≥ 80 cm in women of Asian origin 
(21). The Japanese population is an exception. 
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It has also been noted that for a given BMI, Asians have higher body fat percentage compared 
with Caucasians (22,23). Higher insulin resistance and an increased risk of diabetes may be 
partially attributed to this feature. The differences in anthropometric characteristics are evident 
even in Asian children who are shown to have higher body fat percentage at lower levels of 
body weight (24,25) and also a tendency for abdominal obesity (26). 
In the cohorts of East Asians(27), including Chinese, Japanese, and South Koreans, the 
lowest risk of death was seen among persons with a BMI in the range of 22.6 to 27.5. The 
risk was elevated among persons with BMI levels either higher or lower than that range — 
by a factor of up to 1.5 among those with a BMI of more than 35.0 and by a factor of 2.8 
among those with a BMI of 15.0 or less. A similar U-shaped association was seen between 
BMI and the risks of death from cancer, cardiovascular diseases and other causes. 
A WHO expert consultation concluded in 2004 that Asians generally have a higher 
percentage of body fat than Caucasian people of the same age, sex, and BMI. Also, the 
proportion of Asians with risk factors for type 2 diabetes and cardiovascular disease is 
substantial even below the existing WHO BMI cut-off point of 25 kg/m2. Thus, WHO cut-
off points did not provide an adequate basis for taking action on risks related to overweight 
and obesity in many populations in Asia. The WHO recommended for many Asian 
populations additional trigger points for public health action, which were identified as 23 
kg/m2 or higher, representing increased risk, and 27·5 kg/m2 or higher, as representing 
high risk. The suggested categories are as follows: less than 18·5 kg/m2 underweight; 18·5–
23 kg/m2 increasing but acceptable risk; 23–27·5 kg/m2 increased risk; and 27·5 kg/m2 or 
higher high risk. (3) 
3. Diabetes in Asia 
Type 2 diabetes is now a global health priority.(28) The International Diabetes Federation 
has predicted that the number of individuals with diabetes will increase from 240 million in 
2007 to 380 million in 2025, with 80% of the disease burden in low- and middle-income 
countries.(29) More than 60% of the world’s population with diabetes will come from Asia, 
because it remains the world’s most populous region. The number of individuals with 
diabetes and impaired glucose tolerance (IGT) in each Asian country will increase 
substantially in coming decades (Table 2).(30)  
 
 Diabetes Impaired Glucose Tolerance 
Country 2007 2025 2007 2025 
India 40850 69882 35906 56228 
China 39809 59270 64323 79058 
Japan 6978 7171 12891 12704 
Bangladesh 3848 7416 6819 10647 
Korea 3074 4163 3224 4240 
Total Asia 113536 179742 157067 213218 
All values are in thousands 
Table 2. Top 5 Countries in Asia With the Highest Number of Persons With Type 2 Diabetes 
and Impaired Glucose Tolerance in the Age Group 20 to 79 Years in 2007 and Projected Data 
in 2025 (30) 
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Fig. 1. Number of persons with diabetes in different age group (30) 
 
Deaths attributable to diabetes , Age 20~79 years. 
Fig. 2. Number of Deaths Attributable to Diabetes in Different Regions of the World in 2007 (30) 
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Unlike in the West, where older populations are most affected, the burden of diabetes in 
Asian countries is disproportionately high in young to middle-aged adults. (Figure 1) And 
also the number of deaths attributable to diabetes in Asian Pacific region is extremely 
high.(Figure 2) (30) 
Amid this global epidemic of diabetes, Asian countries undergoing economic and 
nutritional transitions have experienced a particularly notable increase.(30) In China, the 
prevalence of diabetes increased from 1% in 1980 to 5.5% in 2001(31), with much higher 
rates in urban areas such as Shanghai(32). Nearly 10% of Chinese adults residing in affluent 
regions such as Hong Kong and Taiwan have diabetes (33). Among individuals with 
diabetes, two-thirds in mainland China and one-half in Hong Kong and Taiwan remain 
undiagnosed. 
In urban Indian adults, diabetes prevalence increased from 3% in the early 1970s to 12% in 
2000, with a narrowing rural-urban gradient (34). In 2006, the rate of type 2 diabetes in rural 
south India was 9.2%, compared with an increase from 13.9% in 2000 to 18.6% in 2006 in 
urban south India. (35) 
Asians have lower rates of overweightness and obesity than their Western counterparts, 
using conventional definitions. Despite lower BMI, some Asian countries have similar or 
even higher prevalence of diabetes than Western countries.(36) These data confirm that the 
risk of type 2 diabetes starts at a lower BMI for Asians than for Europeans.(37) 
Asian populations, especially those of South Asian descent, are more prone to abdominal 
obesity and low muscle mass with increased insulin resistance compared with their Western 
counterparts. (38,39,40,41,42,43,44) Thus, waist circumference reflecting central obesity is a 
useful measure of obesity-related risk of type 2 diabetes, especially in individuals with 
normal BMI values. (38,45) 
Data suggest that the increased risk of type 2 diabetes in Asian populations may be 
attributed to increased abdominal and visceral adiposity for a given BMI.(46) 
In Asian populations, the amount of visceral fat (including mesenteric fat) and fatty liver 
was significantly associated with subclinical atherosclerosis.(47) In addition, increased waist 
circumference has been associated with substantially increased risk of developing diabetes 
(48,49) as well as increased risk of cardiovascular and all-cause mortality, independent of 
BMI.(50,51,52,53) 
In the 1980s, Japanese researchers first revealed that reduced early insulin response was an 
independent predictor for diabetes.(54) Fukushima et al (55) found that at all stages of 
glucose intolerance, Japanese individuals had reduced early and late phases of insulin 
responses. In Japanese men with normal glucose tolerance, even a small increase in BMI 
produced a decrease in beta cell function disproportionate to that in insulin sensitivity. (56) 
In a sample of Chinese patients with type 2 diabetes, 50% were of normal weight, with low 
BMI correlating with low levels of fasting plasma C-peptide and high glycated hemoglobin 
levels.(57) In a prospective survey of Japanese Americans, visceral fat area and reduced 
incremental insulin response were independent predictors for diabetes. (58) Taken together, 
in some Asian populations, inadequate beta cell response to increasing insulin resistance 
results in a loss of glycemic control and increased risk of diabetes, even with relatively little 
weight gain. 
www.intechopen.com
 
Advanced Bariatric and Metabolic Surgery 286 
Among lean, healthy individuals matched for age, BMI, waist circumference, birth weight, 
and current diet, Asians had higher levels of postprandial glycemia and lower insulin 
sensitivity than Caucasians in response to a 75-g carbohydrate load.(59) These findings raise 
the possibility that Asians are more genetically susceptible to insulin resistance and diabetes 
than Caucasians. 
Asian patients with diabetes continue to exhibit high risk for renal complications. (60) In 
observational studies as well as clinical trials, Asian patients with diabetes were more likely 
to develop end stage renal disease (ESRD) than their Caucasian counterparts. In a 25-year 
prospective survey, 60% of young Japanese patients with type 2 diabetes diagnosed before 
age 35 became blind or had developed ESRD at a mean age of 50. (61)  
4. Bariatric and metabolic surgery in Asia 
The history of bariatric surgery started when Taiwan adopted the JI bypass as the first 
bariatric surgery in Asia in the 1970s. (62) The first gastric partitioning was performed at 
Taiwan in 1981. (63) The first gastric bypass was introduced into Japan in 1982 and the VBG 
into Singapore in 1987. (64,65)  
With the development of laparoscopic surgery, bariatric surgery has entered the realm of 
minimally invasive surgery. Laparoscopic VBG (LVBG) was successfully performed in 
Taiwan in 1998 and emerged as an alternative to the conventional VBG. (66) After the 
success of laparoscopic adjustable gastric banding (LAGB) in Europe and Australia, Asian 
countries also started to perform LAGB since 1999, first in Singapore.(13) Further, 
laparoscopic Roux-en-Y gastric bypass (LRYGBP) was also introduced into Taiwan in 
2000(67) and subsequently proven to be a more effective but complicated bariatric operation 
than LVBG.(68) LRYGBP has also been developed in Japan 2002 and other Asian countries. 
(69). Laparoscopic Sleeve Gastrectomy was introduced into South Korea in 2002 (70)  
Asian Pacific Bariatric Surgery Group (APBSG), which was founded in 2004 and officially 
changed its name to Asian Pacific Metabolic and Bariatric Surgery Society (APMBSS) in 2008, 
held a consensus meeting in 2005 and modified the indication for bariatric surgery for Asian.  
Consensus in Asia-Pacific 2005 (63)  
1. Obese patients with a BMI >37  
2. Obese patients with a BMI >32 and the presence of diabetes or two significant obesity-
related co-morbidities.  
3. Have been unable to lose or maintain weight loss using dietary or medical measures.  
4. Age of patient >18 years and <65 years. Under special circumstance and in consultation 
with a pediatrician, bariatric surgery may be used on children under 18. 
Because bariatric surgery currently is the most effective treatment for type 2 diabetes, 
APBSG not only modified the indications for bariatric surgery but also emphasized its role 
in diabetic treatment. It was the first bariatric guideline of the world to mention a focus 
especially on diabetes. 
In the national report session at the 2nd congress of the International Federation for Surgery 
of Obesity and Metabolic Disorders Asian Pacific Chapter (IFSO-APC), which was held in 
Hokkaido, Japan, in 2011, the representatives of Asian countries reported on their respective 
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situations. According to the session reports, more than 5,500 cases of bariatric and metabolic 
surgery were performed in Asia 2010. India had 3000 cases followed by Taiwan (Figure 3).  
 
Fig. 3. Bariatric and Metabolic Surgery Cases in 2010 (IFSO-APC 2011 National Report) 
Laparoscopic Gastric bypass still formed the majority of the procedures and LSG was 
rapidly increasing. 
A systematic review of bariatric surgery in Asia with citation of 160 papers from Asia was 
also reported IFSO-APC 2011 by Seki Y, et al. The report summarized as Table3.  
 
 Asian  (Seki et al) All 
RYGBP               %EWL 74.8% 61.6% a 
                            Mortality 0% 0.5% in Open, 0.2% in laparoscopic 
LAGB                 %EWL 59.1% 45.5% a 
                            Mortality 0.07% 0.1% 
LSG                    %EWL 67.9% 55.4% b 
                            Mortality 0.32% 0.19% 
a) Buchwald et al. (n=22094, pre-OP mean BMI 46.9 kg/m2), 
b) Brethauer et al. (n=2570, pre-OP mean BMI 51.2 kg/m2) 
RYGBP: Roux en Y Gastric Bypass, LAGB: Laparoscopic Adjustable Gastric Banding, LSG: Laparoscopic 
Sleeve Gastrectomy  
Table 3. Systemic review results of bariatric surgery for Asians. 
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From the current evidence, including 14 studies and 4,257 patients, bariatric surgery for 
Asians is an effective weight loss procedure although long-term data are limited. The 
postoperative mortality rates have been acceptably low.  
Regarding the anti-diabetic effect of bariatric surgery for Caucasians, LRYGB and LSG 
showed similar results. (71) But for East Asians, a prospective randomized control study for 
type 2 diabetes patients by Lee WJ et al.(72) suggested different results. Gastric bypass was 
far superior to LSG on remission of diabetes and metabolic disorders. Duodenal exclusion 
would play significant role in remission of type 2 diabetes for East Asian populations. 
Limitation of remission of diabetes after LSG was also reported (73). Patients with fasting C-
peptide over 6ng/ml could have a very good remission of diabetes and patients with c-
peptide less than 3ng/ml could only have 14% of remission rate of diabetes after LSG. The 
problem is that a majority of East Asian diabetes patients are more prone to having a beta 
cell dysfunction than Caucasians and with fasting C-peptide less than 3 ng/ml (74). These 
results provide us with data showing that Asians, at least East Asians including Taiwanese, 
Chinese, South Korean and Japanese, have a higher rate of remission from type 2 diabetes 
after bypass surgery than with LSG. 
4. IFSO-APC consensus statement 2011 
According to the ethnicity of Asians, the IFSO-Asian Pacific chapter (APC) consensus 
statement was established in 2011. Forty four bariatric experts from the Asia Pacific and 
other regions were chosen to have voting privileges for the IFSO-APC consensus at 2nd IFSO 
APC congress on 24th February 2011 in Rusutsu, Hokkaido, Japan. All voting delegates 
represented their respective societies or countries. The IFSO-APC consensus based upon the 
antecedent statements and guidelines regarding bariatric and metabolic surgery, especially 
in the Asian Pacific region, including the National Institute of Health (NIH) statements (75), 
Obesity Surgery Society of India (OSSI), Japan Society for Surgery of Obesity (JSSO), Asian 
Consensus Meeting on Metabolic Surgery (ACMOMS)(76), Obesity Surgery Society of 
Australia and New Zealand (OSSANZ), APMBSS(63), Diabetes Surgery Summit (DSS)(77) 
and Asian Diabetes Surgery Summit (ADSS). Before voting on the consensus, 
representatives from each society presented their statements or guidelines. These statements 
and guidelines were used to establish the consensus of the IFSO-APC.  A computerized 
audience-response voting system was used to analyze agreement or disagreement with the 
wording of the consensus. 
“Consensus” was established with the agreement of over 75% of delegates and a 
“Viewpoint” was recognized with an agreement between 66% and 75%.  
Results: Ninety five percent of the delegates agreed with the necessity of establishment of 
the IFSO-APC consensus statement, and 98% agreed with the necessity of new indicators for 
Asian patients. 
IFSO-APC Consensus statements 2011    
 Bariatric surgery should be considered for the treatment of obesity for acceptable Asian 
candidates with BMI > 35 regardless of the existence of co-morbidities 
 Agree 75％ Consensus 
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 Bariatric/ GI metabolic surgery should be considered for the treatment of T2DM or 
metabolic syndrome for patients who are inadequately controlled by lifestyle 
alternations or medical treatment for acceptable Asian candidates with BMI > 30 
 Agree 76.7% Consensus  
 The surgical approach may be considered as a non-primary alternative to treat 
inadequately controlled T2DM or metabolic syndrome for suitable Asian candidates 
with BMI > 27.5. 
 Agree 67.5% Viewpoints 
 Any surgery for T2DM or metabolic syndrome for Asian patients with a BMI < 27.5 
should be strictly performed only under clinical study protocols with the informed 
consent of the patient and prior approval from an ethics committee.  
 Agree 88.1% Consensus 
 Any surgery for T2DM or metabolic syndrome for Asian patients with a BMI < 27.5 
should be strictly performed only under clinical study protocols with the informed 
consent of the patient and prior approval from the ethics committee.  
 Agree 88.1% Consensus 
 IFSO-APC generally recommends the procedures below for Bariatric and GI metabolic 
surgery for Asians, currently 
 Gastric bypass, Sleeve gastrectomy, Gastric banding, BPD/DS 
 Agree 95.3% Consensus 
 Although novel GI surgical procedures show promising results for Asians other than 
the four mentioned previously, currently these should be used only in the context of 
IRB approval. 
 Agree 97.6% Consensus 
 Clinical study should be organized by highly experienced bariatric surgeons, with 
experience in over 100 cases of bariatric surgery 
 Agree 80% Consensus 
And another three sentences were agreed to by a majority of the voting delegates to form 
IFSO-APC consensus statements. 
Furthermore, an International Diabetes Federation (IDF) position statement in 2011 March 
(78) also concluded surgery should be considered as an alternative treatment option in 
Asian patients with a BMI between 27.5 and 32.5 kg⁄m2 when diabetes cannot be adequately 
controlled by an optimal medical regimen, especially in the presence of other major 
cardiovascular disease risk factors.  
These results indicate the progress of the Asian region differs from other regions and that it 
will play significant role in progression of metabolic surgery not only in Asia but also all 
over the world. 
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